Back to Agenda
The Evolving Model of Using Artificial Intelligence to Deliver Actionable Regulatory Intelligence
Session Chair(s)
Linda Bowen, MSc, RAC
Chief of Staff, Oncology Regulatory Strategy
Pfizer Inc, United States
The breadth and scope of a regulatory intelligence function is often dependent on the knowledge of its employees, the tools they can access or the consultants they employ. What if we were able to employ machine learning and cognitive computing to help deliver actionable intelligence? This session will look at evolving models for Artificial Intelligence and the challenges in developing and validating these systems.
Join RA Community, Regulatory Intelligence Working Group for a follow up Round Table discussion at 1:00pm, Wednesday June 21st in the Community Corner.
Learning Objective : Discuss artificial intelligence concepts, tools, and case studies in the development of actionable regulatory intelligence.
Speaker(s)
Advances in Regulatory Intelligence Through Artificial Intelligence: Industry Perspective
Patrick Brady, PharmD
IQVIA, United States
Global Head, Therapeutic Innovation & Regulatory Science
Enigma Variations: The Use of Artificial Intelligence in Regulatory Decision Making
Tom Macfarlane, RAC
Accenture Accelerated R&D Services, United Kingdom
Director, Life Sciences
Have an account?